Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Intermittent Fasting 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Overweight 1Obesity 1Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Diet, Healthy × Clear all
NCT01525264 2016-08-18

Breast Cancer Screening Intervention

Jonsson Comprehensive Cancer Center

Phase NA Completed
434 enrolled
Breast

Breast Neoplasms

NCT01304251 2016-01-12

Effects of Short-term Fasting on Tolerance to Chemotherapy

Leiden University Medical Center

Phase NA Completed
13 enrolled
Breast

Intermittent Fasting, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡